Source:http://linkedlifedata.com/resource/pubmed/id/17148084
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11-12
|
| pubmed:dateCreated |
2006-12-6
|
| pubmed:abstractText |
Uptake of hepatitis C (HCV) treatment in HIV-coinfected patients is not well described. Of 2356 HCV-seropositive patients, 180 (7.6%) started HCV treatment with interferon-based therapies. In multivariate Poisson-regression models, there was a 38% increase per year in the incidence of starting HCV treatment (95% CI 26 - 51%, p<0.0001); this increased from 3.9 per 1000 person-years follow-up (PYFU) before 1998 (95% CI 1.6 - 6.1) to 32.6 per 1000 PYFU at/after 2004 (95% CI 22.5 - 42.7). Although prescription of HCV therapy is increasing in HIV-coinfected patients, it remains infrequent and variable across regions of Europe.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0036-5548
|
| pubmed:author |
pubmed-author:CaplinskasSauliusS,
pubmed-author:ChiesiAntonioA,
pubmed-author:EuroSIDA Study Group,
pubmed-author:GasiorowskiJacekJ,
pubmed-author:KirkOleO,
pubmed-author:LundgrenJens DJD,
pubmed-author:MocroftAmandaA,
pubmed-author:PhillipsAndrew NAN,
pubmed-author:RockstrohJurgenJ,
pubmed-author:SorianoVincentV,
pubmed-author:ViardJean-PaulJP
|
| pubmed:issnType |
Print
|
| pubmed:volume |
38
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1092-7
|
| pubmed:dateRevised |
2010-8-12
|
| pubmed:meshHeading |
pubmed-meshheading:17148084-Antiviral Agents,
pubmed-meshheading:17148084-Europe,
pubmed-meshheading:17148084-Female,
pubmed-meshheading:17148084-HIV Infections,
pubmed-meshheading:17148084-Hepatitis C,
pubmed-meshheading:17148084-Humans,
pubmed-meshheading:17148084-Interferons,
pubmed-meshheading:17148084-Male,
pubmed-meshheading:17148084-Multivariate Analysis,
pubmed-meshheading:17148084-Physician's Practice Patterns,
pubmed-meshheading:17148084-Prospective Studies
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C.
|
| pubmed:affiliation |
Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK. a.mocroft@pcps.ucl.ac.uk
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|